🟢 Citius Pharmaceuticals is trading 8.8% up today, extending momentum from yesterday's double-digit gain

Citius Pharmaceuticals is trading at $0.62 (up 8.8%), extending momentum from yesterday's 14.3% regular-session gain to $0.57.

• The move occurs without any fresh company-specific catalysts, such as new earnings, FDA updates, M&A news, or analyst rating changes.
• Shares appear to be continuing a recent upward trend despite a weak healthcare sector backdrop and broadly positive U.S. equity markets.
• The most recent notable update from the company was its fiscal second-quarter 2026 results and business update.